September 25, 2026 (11) Live feed
Historical analysis

CoreCivic CEO Steps Down With Stage Four Pancreatic Cancer Diagnosis

Corecivic, Inc. (CXW) Market cap : at edition (Sep 25, 2026) $3.4B

Management Succession

Company Background

CoreCivic is the nation's largest owner and operator of private correctional, detention, and residential reentry facilities, managing approximately 64 residential facilities with a combined design capacity of 72,000 beds. Based in Brentwood, Tennessee, the company derives roughly half its revenue from federal customers — principally U.S. Immigration and Customs Enforcement and the U.S. Marshals Service — with the remainder from state and local governments. Its approximate market capitalization is $3.4 billion.

The past year has been among the most operationally and financially active in the company's history. Revenue rose 26% year-over-year in the fourth quarter of 2025 and continued climbing through 2026, reaching $684.9 million in the second quarter. Between July and August 2026, CoreCivic sold four detention facilities to the U.S. Department of Homeland Security for aggregate gross proceeds of approximately $2.2 billion, used those proceeds to retire more than $600 million in debt including its 2027 senior notes, and executed a $500 million accelerated share repurchase agreement, with final settlement expected before the end of the second quarter of 2027.

Patrick Swindle had led the company as President and Chief Executive Officer since January 1, 2026, having previously served as President and Chief Operating Officer from January 1, 2025. He stepped into the top role at the start of what became a transformative period for the company.

What Was Disclosed

Swindle resigned as President, CEO, and board member effective September 24, 2026, due to stage four metastatic pancreatic cancer. In the accompanying press release, he stated: "It is with a heavy heart that I am announcing my decision to resign as President and CEO of CoreCivic, as I pursue treatment for stage four metastatic pancreatic cancer." The board simultaneously appointed Lucibeth Mayberry, previously Executive Vice President and Chief Strategy Officer, as his successor. Mayberry was also appointed to the board to fill the vacancy created by Swindle's resignation.

Continue with a free account

Read up to 3 full stories per week — your choice. Pro unlocks the full edition.